SEL PHARMACIE DE SAINT PAUL : revenue, balance sheet and financial ratios

SEL PHARMACIE DE SAINT PAUL is a French company founded 17 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-PAUL-DE-VENCE (06570), this company of category PME shows in 2014 a revenue of 2.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SEL PHARMACIE DE SAINT PAUL (SIREN 509207387)
Indicator 2024 2023 2022 2021 2020 2017 2016 2014 2013 2012
Revenue N/C N/C N/C N/C N/C N/C N/C 2 153 675 € 1 905 520 € 2 830 320 €
Net income 49 744 € 16 657 € 41 585 € 73 753 € -94 745 € 198 593 € 144 035 € 214 405 € 124 356 € 193 750 €
EBITDA N/C N/C N/C N/C N/C N/C N/C 346 065 € 256 082 € 355 792 €
Net margin N/C N/C N/C N/C N/C N/C N/C 10.0% 6.5% 6.8%

Revenue and income statement

In 2024, SEL PHARMACIE DE SAINT PAUL generates positive net income of 50 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2012-2024: 194 k€ -> 50 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

49 744 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 222%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 28%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

221.967%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

28.231%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

34.4%

Solvency indicators evolution
SEL PHARMACIE DE SAINT PAUL

Sector positioning

Debt ratio
221.97 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average

In 2024, the debt ratio of SEL PHARMACIE DE SAINT PAUL (221.97) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
28.23% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of SEL PHARMACIE DE SAINT PAUL (28.2%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 179.48. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

179.477

Liquidity indicators evolution
SEL PHARMACIE DE SAINT PAUL

Sector positioning

Liquidity ratio
179.48 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average -26 pts over 3 years

In 2024, the liquidity ratio of SEL PHARMACIE DE SAINT PAUL (179.48) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SEL PHARMACIE DE SAINT PAUL

Positioning of SEL PHARMACIE DE SAINT PAUL in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SEL PHARMACIE DE SAINT PAUL is estimated at 694 463 € (range 483 613€ - 1 038 956€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
483k€ 694k€ 1038k€
694 463 € Range: 483 613€ - 1 038 956€
NAF 5 année 2024

Valuation method used

Net Income Multiple
49 744 € × 14.0x = 694 463 €
Range: 483 613€ - 1 038 956€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SEL PHARMACIE DE SAINT PAUL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SEL PHARMACIE DE SAINT PAUL

What is the revenue of SEL PHARMACIE DE SAINT PAUL ?

The revenue of SEL PHARMACIE DE SAINT PAUL in 2014 is 2.2 M€.

Is SEL PHARMACIE DE SAINT PAUL profitable?

Yes, SEL PHARMACIE DE SAINT PAUL generated a net profit of 50 k€ in 2024.

Where is the headquarters of SEL PHARMACIE DE SAINT PAUL ?

The headquarters of SEL PHARMACIE DE SAINT PAUL is located in SAINT-PAUL-DE-VENCE (06570), in the department Alpes-Maritimes.

Where to find the tax return of SEL PHARMACIE DE SAINT PAUL ?

The tax return of SEL PHARMACIE DE SAINT PAUL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SEL PHARMACIE DE SAINT PAUL operate?

SEL PHARMACIE DE SAINT PAUL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.